↓ Skip to main content

Overcoming Barriers to the Market Access of Biosimilars in the European Union: The Case of Biosimilar Monoclonal Antibodies

Overview of attention for article published in Frontiers in Pharmacology, June 2016
Altmetric Badge

About this Attention Score

  • Good Attention Score compared to outputs of the same age (69th percentile)
  • Good Attention Score compared to outputs of the same age and source (79th percentile)

Mentioned by

twitter
8 X users

Citations

dimensions_citation
72 Dimensions

Readers on

mendeley
206 Mendeley